Lasa Supergenerics
₹25.1
-0.65 (-2.52%)
19 April, 2024 07:01 BSE: 540702
NSE: LASAISIN: INE670X01014
Start SIP in Lasa Supergenerics
Start SIPLasa Supergenerics Performance
Day Range
- Low 25
- High 26
52 Week Range
- Low 21
- High 41
- Open Price25
- Previous Close26
- Volume56476
Lasa Supergenerics Financials
| Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 27 | 24 | 31 | 35 |
| Operating Expenses Qtr Cr | 26 | 23 | 27 | 31 |
| Operating Profit Qtr Cr | 1 | 1 | 4 | 4 |
| Depreciation Qtr Cr | 3 | 3 | 3 | 4 |
| Interest Qtr Cr | 0 | 1 | 0 | 0 |
| Tax Qtr Cr | -1 | -2 | 6 | -4 |
| Net Profit Qtr Cr | -1 | 0 | -5 | -15 |
Lasa Supergenerics Technicals
EMA & SMA
Current Price
₹25.1
-0.65 (-2.52%)
- Bullish Moving Average
- ___
- 2
- Bearish Moving Average
- ___
- 14
- 20 Day
- ₹25.27
- 50 Day
- ₹26.72
- 100 Day
- ₹27.62
- 200 Day
- ₹27.94
- 20 Day
- ₹24.31
- 50 Day
- ₹27.46
- 100 Day
- ₹29.04
- 200 Day
- ₹27.28
Lasa Supergenerics Resistance and Support
PIVOT
₹25.37
| Resistance | |
|---|---|
| First Resistance | 25.73 |
| Second Resistance | 26.37 |
| Third Resistance | 26.73 |
| RSI | 47.31 |
| MFI | 56.50 |
| MACD Single Line | -0.68 |
| MACD | -0.33 |
| Support | |
|---|---|
| First Resistance | 24.73 |
| Second Resistance | 24.37 |
| Third Resistance | 23.73 |
Lasa Supergenerics Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 75,237 | 4,771,531 | 63.42 |
| Week | 67,665 | 4,320,426 | 63.85 |
| 1 Month | 115,734 | 8,868,675 | 76.63 |
| 6 Month | 199,545 | 12,685,072 | 63.57 |
Lasa Supergenerics Result Highlights
Lasa Supergenerics Synopsis
NSE-Medical-Ethical Drugs
Lasa Supergenerics is involved in the business activities of Manufacture of veterinary preparations. Company’s Total Operating Revenue is Rs. 129.57 Cr. and Equity Capital is Rs. 50.10 Cr. for the Year ended 31/03/2023. Lasa Supergenerics Ltd. is a Public Limited Listed company incorporated on 11/11/2016 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24233MH2016PLC274202 and registration number is 274202.| Market Cap | 126 |
| Sales | 117 |
| Shares in Float | 2.30 |
| No of funds | 1 |
| Yield | 1.14 |
| Book Value | 1.07 |
| U/D Vol ratio | 1 |
| LTDebt / Equity | |
| Alpha | -0.09 |
| Beta | 1.21 |
Lasa Supergenerics
| Owner Name | Mar-24 | Dec-23 | Sep-23 | Jun-23 |
|---|---|---|---|---|
| Promoters | 53.65% | 53.65% | 53.65% | 53.65% |
| Foreign Portfolio Investors | 0.12% | 0.01% | ||
| Individual Investors | 34.15% | 33.76% | 33.88% | 33.98% |
| Others | 12.08% | 12.58% | 12.47% | 12.37% |
Lasa Supergenerics Management
| Name | Designation |
|---|---|
| Dr. Omkar Pravin Herlekar | Chairman & Managing Director |
| Mr. Shivanand G Hegde | Whole Time Director |
| Mr. Ajay Hareshlal Sukhwani | Independent Director |
| Ms. Manali Roop Bhagtani | Independent Director |
| Ms. Ekta Avtar Gurnasinghani | Independent Director |
| Mr. Hardesh Raja Tolani | Independent Director |
Lasa Supergenerics Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Lasa Supergenerics Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-02-13 | Quarterly Results | |
| 2023-11-10 | Quarterly Results | |
| 2023-08-14 | Quarterly Results | |
| 2023-06-07 | Audited Results | (Revised) per share(2.5%)Final Dividend |
| 2023-02-14 | Quarterly Results |
Lasa Supergenerics FAQs
What is Share Price of Lasa Supergenerics ?
Lasa Supergenerics share price is ₹25 As on 19 April, 2024 | 06:47
What is the Market Cap of Lasa Supergenerics ?
The Market Cap of Lasa Supergenerics is ₹125.8 Cr As on 19 April, 2024 | 06:47
What is the P/E ratio of Lasa Supergenerics ?
The P/E ratio of Lasa Supergenerics is -5.9 As on 19 April, 2024 | 06:47
What is the PB ratio of Lasa Supergenerics ?
The PB ratio of Lasa Supergenerics is 1.1 As on 19 April, 2024 | 06:47